Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $17.26, but opened at $18.54. Ascentage Pharma Group International shares last traded at $18.39, with a volume of 108,728 shares traded.
Ascentage Pharma Group International Trading Up 5.4 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Recommended Stories
- Five stocks we like better than Ascentage Pharma Group International
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Options Trading – Understanding Strike Price
- Up 50% in January, Twilio’s Pullback is the Time to Buy
- 3 Small Caps With Big Return Potential
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
